Wayne Linsley is listed as a director on 8 SEC Form D filings by 2 issuers between May 2020 and Jul 2026: Hoth Therapeutics, Inc. (New York, NY — biotechnology — 2021–2023; $15M reported sold to 53 investors) and Silo Pharma, Inc. (Sarasota, FL — pharmaceuticals — 2020–2026; $4.28M reported sold to 47 investors).
What this means 2 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $19.3M sold in total.
Listed alongside Eric Weisblum (5 shared filings), Jeff Pavell (4 shared filings), Kevin Munoz (4 shared filings), Daniel Ryweck (3 shared filings), David Briones (3 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Wayne. Each name links to their own page.
1 of the issuers belongs to the sponsor group Sable Ridge (5 issuers, $44.7M reported sold, 2011–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Sable Ridge has 5 companies on file and $44.7M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 8 public filings for Wayne Linsley and found 7 differences: No amendment in the last 12 months on an offering that may still be open; Wayne Linsley is written 2 different ways on the filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.